<?xml version='1.0' encoding='utf-8'?>
<document id="25584241"><sentence text="Potential Drug - Drug Interactions among Medications Prescribed to Hypertensive Patients." /><sentence text="Drug-drug interactions(DDIs) are significant but avoidable causes of iatrogenic morbidity and hospital admission" /><sentence text="" /><sentence text="To detect potential drug-drug interactions among medications received by hypertensive patients" /><sentence text="" /><sentence text="Patients of both sex and all adult age groups, who were attending medicine out -patient department (OPD) of a tertiary care teaching rural hospital since last six months and were being prescribed antihypertensive drug/s for essential hypertension, were selected for the study" /><sentence text=" Hypertensive patient with co-morbities diabetes mellitus, ischemic heart diseases, congestive heart failure, and chronic renal diseases were also included in the study" /><sentence text=" Potential drug drug interactions were checked with medscape drug interaction software" /><sentence text="" /><sentence text="With the help of medscape drug interaction software, 71" /><sentence text="50% prescriptions were identified having atleast one drug-drug interaction" /><sentence text=" Total 918 DDIs were found in between 58 drug pairs" /><sentence text=" 55" /><sentence text="23% DDIs were pharmacodynamic, 4" /><sentence text="79% pharmacokinetic type of DDIs" /><sentence text=" 32" /><sentence text="24% DDIs were found affecting serum potassium level"><entity charOffset="36-45" id="DDI-PubMed.25584241.s17.e0" text="potassium" /></sentence><sentence text=" 95" /><sentence text="42% DDIs were found significant type of DDIs" /><sentence text=" Drug drug interaction between atenolol &amp; amlodipine was the most common DDI (136) followed by metoprolol and amlodine (88) in this study"><entity charOffset="42-52" id="DDI-PubMed.25584241.s20.e0" text="amlodipine" /><entity charOffset="95-105" id="DDI-PubMed.25584241.s20.e1" text="metoprolol" /><entity charOffset="110-118" id="DDI-PubMed.25584241.s20.e2" text="amlodine" /><pair ddi="false" e1="DDI-PubMed.25584241.s20.e0" e2="DDI-PubMed.25584241.s20.e0" /><pair ddi="false" e1="DDI-PubMed.25584241.s20.e0" e2="DDI-PubMed.25584241.s20.e1" /><pair ddi="false" e1="DDI-PubMed.25584241.s20.e0" e2="DDI-PubMed.25584241.s20.e2" /><pair ddi="false" e1="DDI-PubMed.25584241.s20.e1" e2="DDI-PubMed.25584241.s20.e1" /><pair ddi="false" e1="DDI-PubMed.25584241.s20.e1" e2="DDI-PubMed.25584241.s20.e2" /></sentence><sentence text=" Atenolol and amlodipine ( 25"><entity charOffset="1-9" id="DDI-PubMed.25584241.s21.e0" text="Atenolol" /><entity charOffset="14-24" id="DDI-PubMed.25584241.s21.e1" text="amlodipine" /><pair ddi="false" e1="DDI-PubMed.25584241.s21.e0" e2="DDI-PubMed.25584241.s21.e0" /><pair ddi="false" e1="DDI-PubMed.25584241.s21.e0" e2="DDI-PubMed.25584241.s21.e1" /></sentence><sentence text="92%) was the most common drugs to cause DDIs in our study" /><sentence text="" /><sentence text="We detected a significant number of drug drug interaction in hypertensive patients" /><sentence text=" These interactions were between antihypertensive agents or between hypertensive and drug for co-morbid condition" /><sentence text="" /></document>